With No Lysine Kinase 3 (WNK3); A Target Enabling Package অনুযায়ী Pinkas, D

অন্যান্য লেখক: “…Pinkas, D…”

With no lysine kinase 3 (WNK3); A Target Enabling Package অনুযায়ী Pinkas, D

অন্যান্য লেখক: “…Pinkas, D…”

Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors অনুযায়ী Suebsuwong, C, Pinkas, D, Ray, S, Bufton, J, Dai, B, Bullock, A, Degterev, A, Cuny, G

2-amino-2, 3-dihydro-1H-indene-5-carboxamide-based discoidin domain receptors 1 (DDR1) inhibitors: design, synthesis, and in vivo anti-pancreatic cancer efficacy অনুযায়ী Zhu, D, Huang, H, Pinkas, D, Luo, J, Ganguly, D, Fox, A, Arner, E, Xiang, Q, Tu, Z, Bullock, A, Brekken, R, Ding, K, Lu, X

BTB domain mutations perturbing KCTD15 oligomerisation cause a distinctive frontonasal dysplasia syndrome অনুযায়ী Miller, K, Cruz Walma, D, Pinkas, D, Tooze, R, Bufton, J, Richardson, W, Manning, C, Hunt, A, Cros, J, McGowan, S, Twigg, S, Chalk, R, Staunton, D, Johnson, D, Wilkie, A, Bullock, A

The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms অনুযায়ী Fulcher, L, Bozatzi, P, Tachie-Menson, T, Wu, K, Cummins, T, Bufton, J, Pinkas, D, Dunbar, K, Shrestha, S, Wood, N, Weidlich, S, Macartney, T, Varghese, J, Gourlay, R, Campbell, D, Dingwell, K, Smith, J, Bullock, A, Sapkota, G

Design, synthesis, and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a dua... অনুযায়ী Wang, Z, Zhang, Y, Pinkas, D, Fox, A, Luo, J, Huang, H, Cui, S, Xiang, Q, Xu, T, Xun, Q, Zhu, D, Tu, Z, Ren, X, Brekken, R, Bullock, A, Liang, G, Ding, K, Lu, X

With No Lysine Kinase 3 (WNK3); A Target Enabling Package অনুযায়ী Bullock, A

অন্যান্য লেখক: “…Pinkas, D…”